 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1fh0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.22.43
- Cathepsin V.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
The recombinant enzyme hydrolyzes proteins (serum albumin, collagen) and synthetic substrates (Z-Phe-Arg-NHMec > Z-Leu-Arg-NHMec > Z-Val-Arg-NHMec).
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
proteolysis
|
1 term
|
 |
|
Biochemical function
|
cysteine-type peptidase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
39:12543-12551
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human cathepsin V.
|
|
J.R.Somoza,
H.Zhan,
K.K.Bowman,
L.Yu,
K.D.Mortara,
J.T.Palmer,
J.M.Clark,
M.E.McGrath.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cathepsin V is a lysosomal cysteine protease that is expressed in the thymus,
testis and corneal epithelium. We have determined the 1.6 A resolution crystal
structure of human cathepsin V associated with an irreversible vinyl sulfone
inhibitor. The fold of this enzyme is similar to the fold adopted by other
members of the papain superfamily of cysteine proteases. This study provides a
framework for understanding the structural basis for cathepsin V's activity and
will aid in the design of inhibitors of this enzyme. A comparison of cathepsin
V's active site with the active sites of related proteases revealed a number of
differences, especially in the S2 and S3 subsites, that could be exploited in
identifying specific cathepsin V inhibitors or in identifying inhibitors of
other cysteine proteases that would be selective against cathepsin V.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.A.Adams-Cioaba,
J.C.Krupa,
C.Xu,
J.S.Mort,
and
J.Min
(2011).
Structural basis for the recognition and cleavage of histone H3 by cathepsin L.
|
| |
Nat Commun, 2,
197.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Renko,
J.Sabotic,
M.Mihelic,
J.Brzin,
J.Kos,
and
D.Turk
(2010).
Versatile loops in mycocypins inhibit three protease families.
|
| |
J Biol Chem, 285,
308-316.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Mihelic,
A.Dobersek,
G.Guncar,
and
D.Turk
(2008).
Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
|
| |
J Biol Chem, 283,
14453-14460.
|
 |
|
|
|
|
 |
P.C.Ong,
S.McGowan,
M.C.Pearce,
J.A.Irving,
W.T.Kan,
S.A.Grigoryev,
B.Turk,
G.A.Silverman,
K.Brix,
S.P.Bottomley,
J.C.Whisstock,
and
R.N.Pike
(2007).
DNA accelerates the inhibition of human cathepsin v by serpins.
|
| |
J Biol Chem, 282,
36980-36986.
|
 |
|
|
|
|
 |
A.Rossi,
Q.Deveraux,
B.Turk,
and
A.Sali
(2004).
Comprehensive search for cysteine cathepsins in the human genome.
|
| |
Biol Chem, 385,
363-372.
|
 |
|
|
|
|
 |
D.Turk,
and
G.Guncar
(2003).
Lysosomal cysteine proteases (cathepsins): promising drug targets.
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
203-213.
|
 |
|
|
|
|
 |
M.E.McGrath,
P.A.Sprengeler,
C.M.Hill,
V.Martichonok,
H.Cheung,
J.R.Somoza,
J.T.Palmer,
and
J.W.Janc
(2003).
Peptide ketobenzoxazole inhibitors bound to cathepsin K.
|
| |
Biochemistry, 42,
15018-15028.
|
 |
|
|
|
|
 |
D.C.Greenbaum,
W.D.Arnold,
F.Lu,
L.Hayrapetian,
A.Baruch,
J.Krumrine,
S.Toba,
K.Chehade,
D.Brömme,
I.D.Kuntz,
and
M.Bogyo
(2002).
Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design.
|
| |
Chem Biol, 9,
1085-1094.
|
 |
|
|
|
|
 |
U.Ilangovan,
H.Ton-That,
J.Iwahara,
O.Schneewind,
and
R.T.Clubb
(2001).
Structure of sortase, the transpeptidase that anchors proteins to the cell wall of Staphylococcus aureus.
|
| |
Proc Natl Acad Sci U S A, 98,
6056-6061.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.K.Jain
(2000).
Applications of proteomics in oncology.
|
| |
Pharmacogenomics, 1,
385-393.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|